Company profile RLAY
There is not enough data for Relay Therapeutics login to provide analysis
There is not enough data for Relay Therapeutics login to provide correlation calculation
There is not enough data for Relay Therapeutics login to provide analysis
After 39 days of this quarter the interest is at 73.0. Based on that we can calculate that during remaining 52 days it will total up to 170.0. Relay Therapeutics stock expected interest is significantly higher compared to previous quarter (+50.4%) and same quarter last year (+82.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 39 | 33 -15.4% QoQ | 69 109.1% QoQ | 21 -69.6% QoQ |
| 2020 | 19 -51.3% YoY -9.5% QoQ | 26 -21.2% YoY 36.8% QoQ | 296 329.0% YoY 1038.5% QoQ | 64 204.8% YoY -78.4% QoQ |
| 2021 | 168 784.2% YoY 162.5% QoQ | 59 126.9% YoY -64.9% QoQ | 57 -80.7% YoY -3.4% QoQ | 93 45.3% YoY 63.2% QoQ |
| 2022 | 52 -69.0% YoY -44.1% QoQ | 67 13.6% YoY 28.8% QoQ | 168 194.7% YoY 150.7% QoQ | 66 -29.0% YoY -60.7% QoQ |
| 2023 | 93 78.8% YoY 40.9% QoQ | 124 85.1% YoY 33.3% QoQ | 70 -58.3% YoY -43.5% QoQ | 113 71.2% YoY 61.4% QoQ |
| 2024 | 73 -21.5% YoY -35.4% QoQ | - | - | - |
The average 5 years interest of Relay Therapeutics stock was 6.78 per week. The last year interest of Relay Therapeutics stock compared to the last 5 years has changed by 24.48%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 170.51%.
After 39 days of this quarter the interest is at 61.0. Based on that we can calculate that during remaining 52 days it will total up to 142.0. Relay Therapeutics news expected interest is significantly higher compared to previous quarter (+46.4%) and same quarter last year (+42.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 22 | 76 245.5% QoQ | 170 123.7% QoQ | 27 -84.1% QoQ |
| 2020 | 23 4.5% YoY -14.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 75 -55.9% YoY inf% QoQ | 65 140.7% YoY -13.3% QoQ |
| 2021 | 67 191.3% YoY 3.1% QoQ | 113 inf% YoY 68.7% QoQ | 164 118.7% YoY 45.1% QoQ | 118 81.5% YoY -28.0% QoQ |
| 2022 | 44 -34.3% YoY -62.7% QoQ | 189 67.3% YoY 329.5% QoQ | 31 -81.1% YoY -83.6% QoQ | 30 -74.6% YoY -3.2% QoQ |
| 2023 | 100 127.3% YoY 233.3% QoQ | 23 -87.8% YoY -77.0% QoQ | 79 154.8% YoY 243.5% QoQ | 97 223.3% YoY 22.8% QoQ |
| 2024 | 61 -39.0% YoY -37.1% QoQ | - | - | - |
The average 5 years interest of Relay Therapeutics news was 6.03 per week. The last year interest of Relay Therapeutics news compared to the last 5 years has changed by -17.08%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -18.3%.
There is not enough data for Relay Therapeutics careers to provide analysis
There is not enough data for Relay Therapeutics careers to provide correlation calculation
There is not enough data for Relay Therapeutics careers to provide analysis
There is not enough data for Relay Therapeutics precision medicines to provide analysis
There is not enough data for Relay Therapeutics precision medicines to provide correlation calculation
There is not enough data for Relay Therapeutics precision medicines to provide analysis
There is not enough data for RLY-4008 clinical trial to provide analysis
There is not enough data for RLY-4008 clinical trial to provide correlation calculation
There is not enough data for RLY-4008 clinical trial to provide analysis
There is not enough data for RLY-2608 mutant-PI3Ka inhibitor to provide analysis
There is not enough data for RLY-2608 mutant-PI3Ka inhibitor to provide correlation calculation
There is not enough data for RLY-2608 mutant-PI3Ka inhibitor to provide analysis
There is not enough data for GDC-1971 Phase 1 trial to provide analysis
There is not enough data for GDC-1971 Phase 1 trial to provide correlation calculation
There is not enough data for GDC-1971 Phase 1 trial to provide analysis
There is not enough data for Relay Therapeutics precision medicine discovery to provide analysis
There is not enough data for Relay Therapeutics precision medicine discovery to provide correlation calculation
There is not enough data for Relay Therapeutics precision medicine discovery to provide analysis